Carol Hobgood
Family · Tylertown, MSNPI 1093137309
Payments from drug & device makers
Across 229 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$893
- AstraZeneca$778
- AbbVie$298
- Novo Nordisk$257
- GSK$230
- Lilly USA, LLC$181
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,946100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 44 | $893 |
| AstraZeneca | 39 | $778 |
| AbbVie | 28 | $298 |
| Novo Nordisk | 16 | $257 |
| GSK | 24 | $230 |
| Lilly USA, LLC | 10 | $181 |
| Boehringer Ingelheim | 9 | $142 |
| Astellas Pharma US Inc | 7 | $138 |
| Exact Sciences | 6 | $126 |
| Amgen | 7 | $121 |
| Merck | 4 | $104 |
| Novartis | 5 | $89 |
| Baxter Healthcare | 3 | $88 |
| Dexcom, Inc. | 4 | $81 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Pfizer | 3 | $58 |
| Viatris Specialty LLC | 2 | $48 |
| Lundbeck LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $8 |
How this compares
$3,946 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 117 | $162,697 |
| JardianceEmpagliflozin | 100 | $114,154 |
| LinzessLinaclotide | 124 | $99,644 |
| EliquisApixaban | 125 | $91,819 |
| JanuviaSitagliptin Phosphate | 64 | $63,194 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $43,718 |
| TradjentaLinagliptin | 49 | $37,851 |
| RybelsusSemaglutide | 19 | $29,049 |
| XareltoRivaroxaban | 41 | $27,383 |
| MounjaroTirzepatide | 14 | $21,461 |
| MyrbetriqMirabegron | 20 | $19,497 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $17,468 |
| FarxigaDapagliflozin Propanediol | 17 | $13,912 |
| EntrestoSacubitril/Valsartan | 13 | $11,793 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 52 | $9,104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $257 | $191,745136 claims |
| Boehringer IngelheimJardiance, Tradjenta | $142 | $152,005149 claims |
| AbbVieLinzess | $298 | $99,644124 claims |
| PfizerEliquis | $58 | $91,819125 claims |
| MerckJanuvia, Janumet Xr | $104 | $72,08077 claims |
| GSKTrelegy Ellipta | $230 | $43,71855 claims |
| Lilly USA, LLCMounjaro | $181 | $21,46114 claims |
| Astellas Pharma US IncMyrbetriq | $138 | $19,49720 claims |
| AstraZenecaFarxiga, Symbicort | $778 | $16,51329 claims |
| NovartisEntresto | $89 | $11,79313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Tylertown
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.